Last updated: 11/07/2018 16:34:13
Estimate FP systemic exposure in pediatric subjects age 4-11 years following FP HFA MDI
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Estimate FP systemic exposure in pediatric subjects age 4-11 years following FP HFA MDI
Trial description: Estimate FP systemic exposure in pediatric subjects age 4-11 years following FP HFA MDI
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Abstract: Effect of propellant on fluticasone propionate exposure in pediatric asthma patients. MCHTA, Rashmi, SU, Sheng-Fang, KIM, Kenneth, MILGROM, Henry, DALEY-YATES, Peter, KATHMAN, Steven, and KUNKA, Robert 33rd Annual Meeting of the American College of Clinical Pharmacology 10/3/2004 Phoenix, AZ; USA
Abstract: Fluticasone propionate s ystemic exposure from a methered dose inhaler with and without aerochamber plus spacer in pediatric asthma patients. Mehta, Rashmi 1, Collins, David , Su, Sheng-Fang , Beerahee, Misba , Daley-Yates, Peter , and Kunka, Robert 34th Annual Meeting of the American College of Clinical Pharmacology 9/11/2005 Rockville, MD; USA
Abstract: Pharmacokinetics of fluticasone propionate following a metered dose inhaler containing a hydrofluoroalkane propellant in pediatric and adult asthma patients. Mehta, R. S. Ph. D., Su, S. Ph. D., Andrews, S. S. M. S., Daley-Yates, P. Ph. D., and Kunka, R. Ph. D. 101st International Conference of the American Thoracic Society 5/20/2005 San Diego, CA; USA
Mehta R, Su S, Kim K, Milgrom H, Daley-Yates P, Kathman S and Kunka RL. Effect of Propellant on Fluticasone Propionate Exposure in Pediatric Asthma Patients. Journal of Clinical Pharmacology, 44 (10): 1193, 2004
Medical condition
Asthma
Product
fluticasone propionate, norflurane
Collaborators
Not applicable
Study date(s)
October 2003 to December 2003
Type
Not applicable
Phase
1
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2003-18-12
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website